导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 21.25% | 191/1050 |
| 近一周 | -4.94% | 1065/1104 |
| 近一月 | -3.35% | 398/1102 |
| 近一季 | -1.20% | 295/1092 |
| 近半年 | 13.06% | 217/1070 |
| 近一年 | 22.58% | 218/1018 |
| 近两年 | 61.62% | 421/926 |
| 近三年 | 18.57% | 508/834 |
| 成立以来 | 37.80% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.86% 420/1070 |
18.98% 397/1101 |
- - |
- - |
| 2025 | 12.13% 802/1065 |
0.26% 783/1014 |
3.13% 426/1038 |
8.19% 880/1050 |
0.23% 441/1065 |
| 2024 | -7.13% 728/1011 |
-7.62% 675/960 |
-5.44% 654/983 |
5.01% 887/991 |
1.24% 265/1011 |
| 2023 | -6.66% 244/952 |
4.16% 365/880 |
-1.60% 277/895 |
-3.99% 244/915 |
-5.15% 524/952 |
| 2022 | -26.51% 542/867 |
-15.79% 297/773 |
5.21% 509/806 |
-16.44% 647/845 |
-0.75% 480/867 |
| 2021 | 6.01% 290/740 |
-5.54% 363/580 |
13.16% 285/659 |
1.65% 194/704 |
-2.44% 528/740 |
| 2020 | 40.83% 294/554 |
-3.49% 246/419 |
21.67% 256/466 |
12.01% 201/517 |
7.07% 404/554 |
| 2019 | 51.00% 141/410 |
29.20% 419/1146 |
1.65% 190/1228 |
3.05% 252/390 |
11.57% 121/410 |
| 2018 | -20.60% 90/349 |
- - |
-4.04% 165/990 |
-1.40% 263/1000 |
-12.69% 687/1080 |
| 2017 | 9.12% 138/285 |
- - |
- - |
- - |
- - |
| 2016 | -6.78% 53/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 前海开源强势共识100强股票 VS. 东吴新产业精选股票A(580008) |